Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial

Fig. 4

Alanine transferase (ALT) before treatment and at the end of the study. ALT blood level was divided to three categories: black-within normal range-(ALT < 35 U/L); white – elevated but less than twice the upper normal limit (35 ≤ ALT< 70 U/L); grey – more than twice the upper normal limit (ALT≥70 U/L). baseline dispersion was compared to end of study dispersion (12 weeks after last treatment) (p < 0.001, Pearson Chi-Square test). Data is presented as number (%)

Back to article page